associated product failures mainly because neither physicians nor shoppers have all of the knowledge needed to make sufficient judgments of products quality and authorized tort therapies are gradual, inefficient, and intensely high-priced. The modifications for the CGMP regulation would require manufacturers to increase [Page 52644] their good qual